S66 0.00% 15.0¢ star combo pharma limited

that’s spot on, growth via acquisition is perfectly fine, but...

  1. 880 Posts.
    lightbulb Created with Sketch. 156
    that’s spot on, growth via acquisition is perfectly fine, but don’t overpay.
    looking at how BKL has trended over the last 12 months suggests the EBITDA multiple, even against forecast FY19 was way too much.
 
watchlist Created with Sketch. Add S66 (ASX) to my watchlist
(20min delay)
Last
15.0¢
Change
0.000(0.00%)
Mkt cap ! $20.26M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 31268 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 10000 1
View Market Depth
Last trade - 16.12pm 23/08/2024 (20 minute delay) ?
S66 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.